Therefore, 1,25(OH)2D inhibition of TACE (Tumor necrosis factor Alpha Converting Enzyme, also known as ADAM17), a metalloproteinase overexpressed in several cancer types [164], may further explain its antiproliferative effects [165]. This evidence concerns the gene ADAM17 and cancer.